A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma

NCT01564914 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Glioblastoma Multiforme

Interventions

DRUG: TRC105
DRUG: Bevacizumab

Sponsor

Tracon Pharmaceuticals Inc.

Collaborators

[object Object]
[object Object]